ArticleBJR open2025

The effects of anti-PD-1 therapy on programmed death-ligand 1 expression and glucose metabolism of normal organs in patients with advanced non-small cell lung cancer.

Matthew Severyn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.